Pathogenesis and current approaches to control of varicella-zoster virus infections.
about
Microbiology laboratory and the management of mother-child varicella-zoster virus infectionReducing the burden of Herpes Zoster in ItalyApproved Antiviral Drugs over the Past 50 YearsSex differences underlying orofacial varicella zoster associated pain in rats.The varicella-zoster virus portal protein is essential for cleavage and packaging of viral DNA.Focal encephalitis following varicella-zoster virus reactivation without rash in a healthy immunized young adult.Evaluation of the economic burden of Herpes Zoster (HZ) infection.Seroepidemiology of varicella-zoster virus in Korean adolescents and adults using fluorescent antibody to membrane antigen test.Disseminated, persistent, and fatal infection due to the vaccine strain of varicella-zoster virus in an adult following stem cell transplantation.Use of Saliva to Identify Varicella Zoster Virus Infection of the GutVaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells.Prevalence and Persistence of Varicella Antibodies in Previously Immunized Children and Youth With Perinatal HIV-1 Infection.Biological Plausibility of a Link Between Arterial Ischemic Stroke and Infection With Varicella-Zoster Virus or Herpes Simplex VirusAsthma and risk of breakthrough varicella infection in children.In vitro system using human neurons demonstrates that varicella-zoster vaccine virus is impaired for reactivation, but not latency.Epidemiology of Herpes Zoster Ophthalmicus: Recurrence and ChronicityVaricella zoster virus infection.Contemporary infectious exanthems: an update.Varicella-Zoster Virus Gastritis: Case Report and Review of the Literature.Characterization and phylogenetic analysis of Varicella-zoster virus strains isolated from Korean patients.Genotype analysis of ORF 62 identifies varicella-zoster virus infections caused by a vaccine strain in children.Varicella-zoster immunoglobulin treatment in pregnant women in Denmark from 2005 to 2015: descriptive epidemiology and follow-up.Relationship between cell-mediated immunity to Varicella-Zoster virus and aging in subjects from the community-based Shozu Herpes Zoster study.The herpes simplex virus 1 UL51 protein interacts with the UL7 protein and plays a role in its recruitment into the virion.Satellite lesions accompanying herpes zoster: a new prognostic sign for high-risk zoster.Fifteen years of routine childhood varicella vaccination in the United States-strong decrease in the burden of varicella disease and no negative effects on the population level thus far.A Concordance Study of the Altona RealStar Varicella-Zoster Virus Real-Time Quantitative PCR and In House Conventional Qualitative PCR.Decreased Immunity to Varicella Zoster Virus in Giant Cell Arteritis.Varicella Virus Vaccination in the United States.Studies with herpes zoster vaccines in immune compromised patients.Pregnancy and infection: using disease pathogenesis to inform vaccine strategy.Persistence of immune response to an adjuvanted varicella-zoster virus subunit vaccine for up to year nine in older adults.Background paper to the decision not to recommend a standard vaccination with the live attenuated herpes zoster vaccine for the elderly in Germany : Statement of the German Standing Committee on Vaccination (STIKO) at the Robert Koch Institute (RKI)Varicella zoster virus transmission dynamics in Vojvodina, Serbia.Pharyngeal dysphagia due to Varicella zoster virus meningoradiculitis and full recovery: Case report and endoscopic findings.Herpes zoster in psoriasis patients undergoing treatment with biological agents: prevalence, impact, and management challenges.Herpes Zoster DNA Vaccines with IL-7 and IL-33 Molecular Adjuvants Elicit Protective T Cell Immunity
P2860
Q26738745-ADCA134A-3EDE-454A-87A3-414B95D4AD9CQ26998625-B1D2863A-3F35-4D9B-BD5C-320712617B66Q27755387-E829833E-7E7A-4490-9B64-51C28ABB34C3Q33702943-817FF28A-A908-4357-B5C7-C046F1035A33Q33900399-AAE313A7-0904-4670-8AF1-5674B850E03EQ34366626-4DA7532B-4D1B-408F-A4CB-4B0B75394538Q35498396-0302FB3F-5636-4D07-96ED-B6CE64C8D359Q35559555-9E425256-EFB6-423E-A569-2B8F365A8937Q35661764-8CE6338B-D86C-4FC4-8055-595201D756CFQ36167494-F361A1D8-32E9-4430-B45A-418D3CE1D974Q36276185-100F5EB8-36E2-4FC6-BAAF-57FCC8427EDFQ36369132-D90FE324-8417-460C-8169-A31A92DD3992Q36614586-FB27C362-D63B-4D38-B222-11ADB50DEE8BQ36841455-7FCC35FE-7A1B-4086-90D8-7C2F184806AEQ36866120-EDF349A9-C6DD-4837-AC8D-2BD7BBE4789EQ37038580-7D2E52C2-2051-4EBD-B190-F4F89A315B81Q37738789-1C6CD5E5-D397-474F-AF3D-D98BC92BF43BQ38795858-66F8685F-7D42-4EAC-9C3D-9499BA8FF4D7Q39222537-D4642414-1866-46DD-8934-18BB0154575CQ40104586-CC5FEFA4-F71E-4ADA-97D1-A5497FA45277Q40330700-D1FE6D4E-BA3B-4413-AF04-FA6D2872855AQ40571942-FDB908D3-A155-4351-9432-D7C61EA6F8F9Q40612256-49BA3716-53CD-432D-8DE6-295927F759A4Q41568811-9F710B10-12B3-4E78-A64D-5DB7CB0E3A2AQ41628201-DFE5D939-74AD-4727-8F34-E2E88228CDA7Q41880259-6D4B329C-F85D-46E0-876B-75E5A7CBBB4FQ41925755-61D35AC6-A40D-4909-B080-68D26FB6AA00Q43271288-056C3275-6B82-45A1-9181-EDDEBED1BD2DQ45324301-7ECAFF25-FF2B-425E-8C03-AFB53D768911Q47605669-F33EE532-49F5-4E8E-B931-56491F03E9C0Q48504993-C38CA43B-7DF4-4066-9E17-A97EA6CDF0FCQ50105407-FD88015A-508F-40D2-A732-CB054624B8EDQ50210244-CBA31AB8-0C6D-450A-BBD0-7DBFBDDB2B58Q50420837-DA266F62-376E-40FD-8759-800F0D63CCE9Q53841891-0265EBB3-1434-4348-B7A4-E100F2F7CC54Q54508929-8BBA270A-5926-49A5-BD6B-FCE205CE508EQ58584452-9C99068C-20E5-46A3-B141-B26050F2B5CF
P2860
Pathogenesis and current approaches to control of varicella-zoster virus infections.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pathogenesis and current approaches to control of varicella-zoster virus infections.
@en
Pathogenesis and current approaches to control of varicella-zoster virus infections.
@nl
type
label
Pathogenesis and current approaches to control of varicella-zoster virus infections.
@en
Pathogenesis and current approaches to control of varicella-zoster virus infections.
@nl
prefLabel
Pathogenesis and current approaches to control of varicella-zoster virus infections.
@en
Pathogenesis and current approaches to control of varicella-zoster virus infections.
@nl
P2860
P356
P1476
Pathogenesis and current approaches to control of varicella-zoster virus infections.
@en
P2093
Anne A Gershon
Michael D Gershon
P2860
P304
P356
10.1128/CMR.00052-13
P407
P577
2013-10-01T00:00:00Z